Free Redacted Document - District Court of Delaware - Delaware


File Size: 24.0 kB
Pages: 4
Date: June 9, 2006
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 701 Words, 4,107 Characters
Page Size: Letter (8 1/2" x 11")
URL

https://www.findforms.com/pdf_files/ded/8291/62-1.pdf

Download Redacted Document - District Court of Delaware ( 24.0 kB)


Preview Redacted Document - District Court of Delaware
Case 1:04-cv-00939-GMS

Document 62

Filed 06/09/2006

Page 1 of 4

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE MERCK & CO., INC., Plaintiff, v. TEVA PHARMACEUTICALS USA, INC. Defendant. ) ) ) ) ) ) ) ) )

C.A. NO. 04-939 (GMS)
REDACTED VERSION

APPENDIX OF EXHIBITS TO OPENING BRIEF IN SUPPORT OF MOTION OF MERCK & CO., INC. TO REOPEN FACT AND EXPERT DISCOVERY AND OTHERWISE STAY THIS ACTION OF COUNSEL: John F. Lynch HOWREY, LLP 750 Bering Drive Houston, TX 77057-2198 713.787.1400 Nicolas G. Barzoukas Suzy S. Harbison Jason C. Abair WEIL, GOTSHAL & MANGES 700 Louisiana, Suite 1600 Houston, TX 77002 713.546.5000 Paul D. Matukaitis MERCK & CO., INC. One Merck Drive Whitehouse Station, NJ 08889-0100 908.423.1000 Edward W. Murray Gerard M. Devlin MERCK & CO., INC. 126 E. Lincoln Avenue RY28-320 Rahway, NJ 07065-0907 732.594.4000 Original Filing Date: June 9, 2006 Redacted Filing Date: June 9, 2006 MORRIS, NICHOLS, ARSHT & TUNNELL LLP Mary B. Graham (# 2256) James W. Parrett, Jr. (#4292) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899-1347 302.658.9200 Attorneys for Plaintiff Merck & Co., Inc.

Case 1:04-cv-00939-GMS

Document 62

Filed 06/09/2006

Page 2 of 4

TABLE OF EXHIBITS EXHIBIT A B C United States Patent 5,994,329 United States Patent 6,432,932 Merck & Co., Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-85.) To Defendant Teva Pharmaceuticals USA, Inc. C.A. No. 04-939. Expert Report of Dr. Sunil Wimalawansa, February 1, 2006 {Teva Confidential} Expert Report of David Markowitz, M.D., March 22, 2006 {Teva Confidential} Provisional Patent Application 60/433,685 December 16, 2002 International Publication Number WO 2004/058235 A2 Hearing Transcript, June 2, 2006, C.A. No. 04-939 Trial Transcript, March 4, 2003, C.A. No. 01-048 (JJF) Deposition Transcript, Christopher Pelloni, October 23, 2002, C.A. No. 01-048 (JJF) {Teva Confidential} Teva Ltd. Website Teva Pharmaceuticals Schedule of Documents Withheld from Production on the Basis of Attorney/Client Privilege and/or Attorney Work Product Immunity. C.A. No. 01-048 (JJF) {Teva Confidential} Teva Pharmaceuticals U.S.A., Inc.'s Schedule of Documents Withheld from Production. C.A. No. 04-939 Teva Pharmaceuticals USA Website Merck's Motion to Add Teva's U.S. Patent No. 6,476,006 to the Record as Plaintiff's Trial Exhibit 301, April 11, 2003, C.A. 01-048 (JJF) Order Granting Merck's Motion to add US Patent 6,476,006, July 22, 2003, C.A. No. 01-048 (JJF) Deposition Transcript David Markowitz, May 31, 2006, C.A. No. 04939

D E F G H I J K L

M N O O Tab 1 P

Case 1:04-cv-00939-GMS

Document 62

Filed 06/09/2006

Page 3 of 4

Q R S T U V
524193

Kenyon Letter, December 11, 2002 Teva Pharmaceuticals USA, Inc.'s Post-Trial Brief, March 28, 2003, C.A. No. 01-048 (JJF) {REDACTED} Teva Pharmaceuticals USA, Inc.'s Post-Trial Reply Brief, April 11, 2003, C.A. No. 01-048 (JJF) Merck & Co., Inc. v. Teva Pharmaceuticals USA, Inc., 288 F Supp 2d 601 (D.Del. 2003) Reply Brief for Defendant-Appellant Teva Pharmaceuticals USA, Inc. US Court of Appeals for the Fed. Cir. No. 04-1005 Merck & Co., Inc. v. Teva Pharmaceuticals USA Inc., 395 F 3d 1364 (Fed. Cir. 2005)

Case 1:04-cv-00939-GMS

Document 62

Filed 06/09/2006

Page 4 of 4

CERTIFICATE OF SERVICE I hereby certify that on June 9, 2006, I caused the foregoing to be electronically filed with the Clerk of the Court using CM/ECF which will send electronic notification of such filing to the following: Josy Ingersoll, Esquire YOUNG CONAWAY STARGATT & TAYLOR, LLP The Brandywine Building 1000 West Street, 17th Floor Wilmington, DE 19801

Additionally, I hereby certify that true and correct copies of the foregoing were caused to be served on June 9, 2006 upon the following individuals in the manner indicated: BY HAND AND E-MAIL Josy Ingersoll, Esquire YOUNG CONAWAY STARGATT & TAYLOR, LLP The Brandywine Building 1000 West Street, 17th Floor Wilmington, DE 19801 BY E-MAIL James Galbraith, Esquire KENYON & KENYON One Broadway New York, NY 10004

/s/ Mary B. Graham (#2256)
Mary B. Graham (#2256)

28